Home
About
News
Products
Service
Recruit
Contact us
Chinese
Company news
Company micro text
Individualized target detection scheme for non-small cell lung cancer
Currently, the morbidity and mortality of lung cancer ranks first among all malignant tumors in China. Non-small cell lung cancer patients account for 80-85% of the total number of lung cancer patients,
2022-09-30
Say goodbye to protective clothing, Haijili helps "zero-contact" nucleic acid sampling
Wuhan Hijili Bio is a bio-high-tech enterprise co-founded by a team of Chinese and American scientists and entrepreneurs. The company focuses on the field of precision medicine, and its products cover the fields of tumor individualized diagnosis and cardiovascular individualized diagnosis, infectious disease screening, medical testing services, medical inspection and analysis instruments, etc. On the road of precision medicine, Hijili Bio is willing to work with you to create a better future!
2022-05-07
